⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL27400441 | 0.92 | — | — | |
| Urea SCHEMBL28468404 | 0.73 | — | — | |
| SCHEMBL17771899 | 0.72 | — | — | |
| SCHEMBL5422227 | 0.70 | — | — | |
| SCHEMBL156118 | 0.67 | — | — | |
| SCHEMBL1358988 | 0.67 | — | — | |
| SCHEMBL11312483 | 0.67 | — | — | |
| SCHEMBL2366958 | 0.67 | — | — | |
| SCHEMBL22345974 | 0.67 | — | — | |
| SCHEMBL774078 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1856 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3623372-B1 | PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS | VALO HEALTH INC (US) | 2026-02-04 | — | — | EP | claimed |
| US-20250171464-A1 | THERAPEUTIC COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2025-05-29 | — | — | US | claimed |
| US-12275745-B2 | Therapeutic compounds and methods of use | GENENTECH, INC. (US) | 2025-04-15 | — | — | US | claimed |
| US-12110276-B2 | Pyrazolo compounds and methods of use thereof | GENENTECH, INC. (US) | 2024-10-08 | — | — | US | claimed |
| CN-118317949-A | Isoindolines as PMS2 inhibitors | 奈奥芬莱有限公司 | 2024-07-09 | — | — | CN | claimed |
| US-20240190849-A1 | AMINOPYRIMIDINE COMPOUNDS AND METHODS OF THEIR USE | TYRA BIOSCIENCES, INC. | 2024-06-13 | — | — | US | claimed |
| EP-3833438-B1 | SUBSTITUTED BENZIMIDAZOLES AS PAD4 INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2024-02-07 | — | — | EP | claimed |
| CN-117479943-A | EGFR inhibitors and PERK activators in combination therapies and use thereof for treating cancer | 基因泰克公司 | 2024-01-30 | — | — | CN | claimed |
| CN-110483486-B | Crystal form of oxtinib ketorolac and preparation method thereof | 鲁南制药集团股份有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-116801720-A | Novel agrochemical compositions comprising 3-substituted benzamidine compounds and uses thereof | 皮埃企业有限公司 | 2023-09-22 | — | — | CN | claimed |
| WO-2017013138-A1 | POLYMERIC PARTICLES | LIFE TECHNOLOGIES AS (NO) | 2017-01-26 | — | — | WO | claimed |
| CN-104177408-B | (Z) preparation method of-2-(5-dichlor-phosphoryl amino-1,2,4-thiadiazoles-3-base)-2-ethoxyimino chloroacetic chloride | 衡水衡林生物科技有限公司 | 2016-09-07 | — | — | CN | claimed |
| WO-2016095089-A1 | ERK INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2016-06-23 | — | — | WO | claimed |
| CN-104177408-A | Preparation method of (Z)-2-(5-dichlorophosphorylamino-1,2,4-thiadiazolyl-3-yl)-2-ethoxyiminoacetyl chloride | HENGSHUI HENLIN BIOTECH CO LTD | 2014-12-03 | — | — | CN | claimed |
| US-5578592-A | ANTIBIOTICS | PFIZER INC. (US) | 1996-11-26 | — | — | US | claimed |
| EP-0689540-A1 | CARBACEPHALOSPORIN COMPOUND, THEIR PREPARATION AND USE | PFIZER INC. (US) | 1996-01-03 | — | — | EP | claimed |
| EP-0629204-A1 | CEPHALOSPORIN DERIVATIVES | PFIZER INC. (US) | 1994-12-21 | — | — | EP | claimed |
| WO-1994021633-A1 | CARBACEPHALOSPORIN COMPOUND, THEIR PREPARATION AND USE | SMITHKLINE BEECHAM PLC (GB) | 1994-09-29 | — | — | WO | claimed |
| WO-1993018044-A1 | CEPHALOSPORIN DERIVATIVES | SMITHKLINE BEECHAM PLC (GB) | 1993-09-16 | — | — | WO | claimed |
| EP-0010440-B1 | PYROMELLITIC DIIMIDES, PROCESSES FOR THEIR PREPARATION, THESE COMPOUNDS IN ORALLY ADMINISTRABLE FORM FOR USE IN INCREASING THE FEED EFFICIENCY OF A RUMINANT ANIMAL AND COMPOSITIONS FOR THIS PURPOSE CONTAINING THEM | MERCK & CO. INC. (US) | 1983-01-26 | — | — | EP | claimed |